CAMBRIDGE, Mass. & RIYADH, Saudi Arabia--(BUSINESS WIRE)--In a landmark initiative poised to transform healthcare in the Kingdom of Saudi Arabia, Boston Oncology and King Fahd Medical City (KFMC) have signed a Letter of Intent to collaborate on the localization of Cell & Gene Therapy.

马萨诸塞州剑桥和沙特阿拉伯利雅得——（商业新闻短讯）——在一项具有里程碑意义的计划中，波士顿肿瘤学和法赫德国王医疗城（KFMC）签署了一份意向书，旨在合作定位细胞和基因治疗。

The signing ceremony, attended by His Excellency Eng. Abdulaziz AlRamaih, Deputy Minister of Health for Planning and Development, marks a significant step forward in advancing the Kingdom’s medical capabilities and achieving the ambitious goals set forth in Vision 2030.

负责规划和发展的卫生部副部长阿卜杜勒·阿齐兹·阿尔拉迈赫（Eng.Abdulaziz AlRamaih）阁下出席了签字仪式，标志着在提高沙特的医疗能力和实现《2030年愿景》中提出的宏伟目标方面迈出了重要一步。

A Milestone in Healthcare Transformation

医疗保健转型的里程碑

Dr. Fahad Al-Ghofaili, KFMC CEO, expressed his enthusiasm: “Localizing Cell & Gene Therapy in KFMC is an important step to increase local capabilities in advanced treatments and medical technologies, contributing to the goals of the Healthcare Transformation Project.” [Translated from Arabic]

KFMC首席执行官Fahad Al-Ghofaili博士表达了他的热情：“在KFMC中定位细胞和基因治疗是提高当地先进治疗和医疗技术能力的重要一步，有助于实现医疗保健转型项目的目标。”

Impact for Patients

Boston Oncology, renowned for its customer-centered model, brings extensive expertise in localizing technology. Laser-focused on the real-world needs of patients and hospitals, Boston Oncology is positioned to provide cutting-edge technologies and Cell & Gene Therapies through this partnership. This collaboration will establish a local treatment option, relieving bottlenecks in therapy provision and improving patient outcomes.

波士顿肿瘤学以其以客户为中心的模式而闻名，在本地化技术方面拥有广泛的专业知识。Laser专注于患者和医院的现实需求，波士顿肿瘤学将通过这种合作关系提供尖端技术以及细胞和基因疗法。这种合作将建立一种局部治疗选择，缓解治疗提供的瓶颈并改善患者的预后。

The resulting Research & Development and clinical trials will significantly contribute to innovative advancements in the healthcare sector of Saudi Arabia..

由此产生的研发和临床试验将为沙特阿拉伯医疗保健部门的创新进步做出重大贡献。。

Dr. Abdullah Baaj, CEO of Boston Oncology, described the partnership: “KFMC brings world-class clinicians and infrastructure, making it a destination for patients throughout the region. Joining forces to localize Cell & Gene Therapy is a transformative step towards our mission to impact the lives of one billion patients.”.

波士顿肿瘤学首席执行官阿卜杜拉·巴吉（AbdullahBaaj）博士描述了这种合作关系：“KFMC带来了世界级的临床医生和基础设施，使其成为整个地区患者的目的地。联合力量将细胞和基因治疗本地化是朝着我们影响10亿患者生活的使命迈出的变革性一步。”。

About Boston Oncology Cell & Gene Therapy

关于波士顿肿瘤细胞与基因治疗

Boston Oncology is an innovative life science company with a mission to impact the lives of one billion patients by 2030. With corporate headquarters in Cambridge, Massachusetts, and operations throughout the world, the company is focused on bringing patient-centered solutions and advanced treatment modalities to growing markets.

波士顿肿瘤学是一家创新的生命科学公司，其使命是到2030年影响10亿患者的生活。该公司总部位于马萨诸塞州剑桥市，业务遍及全球，专注于将以患者为中心的解决方案和先进的治疗方式带入不断增长的市场。

Its new Cell & Gene Therapy entity establishes a fully localized offering to deliver personalized treatments that address the unique genetic profiles of patients. By partnering with leading medical institutions and leveraging leading-edge technologies, Boston Oncology CGT is expanding the company’s legacy of transformative advancements in healthcare..

其新的细胞与基因治疗实体建立了一个完全本地化的产品，以提供针对患者独特遗传特征的个性化治疗。通过与领先的医疗机构合作并利用领先的技术，波士顿肿瘤学CGT正在扩大公司在医疗保健领域的变革性进步遗产。。

Learn more at https://bostononcology.com/.

Learn more at https://bostononcology.com/.

About King Fahd Medical City

关于法赫德国王医疗城

King Fahad Medical City (KFMC) in Riyadh, Saudi Arabia, stands as one of the largest and most rapidly expanding medical complexes in the Middle East, with a capacity of 1,200 beds. Operating within the second health cluster, KFMC consists of four hospitals and four specialized medical centers, offering comprehensive healthcare services.

位于沙特阿拉伯利雅得的法哈德国王医疗城（KFMC）是中东最大、发展最快的医疗综合体之一，拥有1200张床位。KFMC在第二个健康集群内运营，由四家医院和四个专业医疗中心组成，提供全面的医疗保健服务。

Known for its advanced medical technologies and high standard of care, KFMC serves over 30,000 inpatients and 500,000 outpatients annually. The institution is committed to excellence in clinical services, medical education, research, and continuous improvement in healthcare..

KFMC以其先进的医疗技术和高标准的护理而闻名，每年为30000多名住院患者和500000名门诊患者提供服务。该机构致力于卓越的临床服务、医学教育、研究和医疗保健的持续改进。。

Learn more at https://www.kfmc.med.sa/.

了解更多信息，请访问https://www.kfmc.med.sa/.